MIB Startup Studio: build & scale your immunology startup.
I’m building my spinoff or startup project MIB Startup Studio supports projects emerging from French public research, with operational and financial support provided by the network’s partners. Available from 2027.
My startup is already incorporated Startups and SMEs worldwide can apply for membership and gain access to a highly qualified network of researchers, clinicians, technology platforms, industry decision-makers, investors and mentors.
Applications for 2026 are closed. Leave your details to hear when the program opens in 2027.
A program supporting the creation of immunology startups, with a multi-partner approach and non-dilutive funding. High priority for projects spinning off from a French public research institution.
Opens: 2027
Apply to MIB Startup Studio if:
- Your startup is already incorporated
- It has a therapeutic area of application relevant to immunology
- Pre-seed, Seed and Growth stage
What MIB Startup Studio brings you
- A structured program
- Help unlocking scientific, clinical, industrial or investment bottlenecks
- Guidance and life lessons from experienced mentors
- Tailored one-on-one support
- Access to the MIB network
- International networking in immuno
Not incorporated yet?
Bringing immunology’s key players together around founders.
MIB Startup Studio is a one-stop-shop opening the doors to laboratories, technology transfer offices, incubators, industry and investors. Projects from public research anywhere in France find a coordinated pathway, from scientific assessment to first partnerships. Founders can then focus on their science and its benefit to patients.
Six most valuable players united around your project.
From basic research to market access, every link in the MIB ecosystem connects with your startup at the right moment.
Researchers
Over 40 years of immunology research in Marseille, working for your science.
Clinicians
Clinical expertise rooted in 170,000 immunology patients followed each year in Marseille, to sharpen the rationale, endpoints and evidence of your clinical project.
Technology platforms
More than 80 biotech platforms on-site, including immune-specific platforms B-cell screening to CAR-T manufacturing. Data libraries available.
Investors
Seed and Series A investors active in immunology, brought in at the right moment.
Mentors
Founders, clinicians, investors – and serial biotech founders, who have been there before.
MIB Startup Studio’s workstreams.
Four workstreams with an immuno spin – including regulatory requirements for biologics, the specifics of rare diseases, and expectations in data quality. The program combines group workshops, peer exchange and one-on-one support, and concludes with a pitch to investors and partners. Content is indicative and tailored to each cohort.
Build the company
Strengthen the evidence
Fundraising
Market access
Applications are closed. Join the waitlist to hear when the next round opens.
Public partners
Private partners
MIB Startup Studio brings together players from the pharmaceutical and investment sectors through an industry and investor adboard, for early feedback against market signals.
The people in your corner.
Founders, clinicians, investors and operators who have been there before.
Mentors
Hind Ouzzani
Eighteen years in strategy, operations and transformation, including at Bain & Company, YouTube and Google Southern Europe. At MIB Startup Studio, she supports founders on the business and organizational decisions that turn a scientific project into a company.
Aniko V. Fejes
Extensive experience in strategic healthcare partnerships and business development, spanning academia, startups and pharma. In Business Development at AOP Health, she helps founders sharpen their value proposition and pitch, and build effective collaborations with pharmaceutical companies.
Nicholas Kirk
Founder of Markovian, he invests in seed-stage deeptech across Europe and the UK, including biotech, semiconductors and applied AI. He brings an early-stage investor’s perspective on technology, valuation and market, and helps founders prepare for investor relations.
Jack Elands
Speakers
Houda Beltaief
Jack Elands
Edwin Moses
A home base for founders, in the heart of Marseille.
Coworking, quiet rooms and a lounge where the ecosystem actually meets. It is a place to build, host mentors and partners, and feel part of an international project from day one, rooted in Marseille’s health and innovation ecosystem. The perk? A rooftop with seaside views.
Frequently asked questions.
Who can apply?
For now, already incorporated startups in immunology and related therapeutic areas, from seed to growth stage. From 2027, a dedicated program will open for researchers planning to create a startup.
Do I need to be based in Marseille or relocate?
No relocation needed. Most of the program runs in a hybrid format, with access to the Marseille space as you need it.
When does the program run?
The next activities launch in Q2 2027.
What is the format?
A program built around four workstreams, combining group workshops, peer exchange and tailored one-on-one support. Two cohorts a year, in summer and winter.
How are startups selected?
A selection committee of scientific, industry and innovation experts reviews applications on scientific excellence, founding team, fit with MIB’s focus areas, maturity, market potential, IP strategy and execution capability.
Does MIB Startup Studio take equity?
No. Participation is non-dilutive: MIB Startup Studio takes no stake in your startup.
What’s happening at MIB Startup Studio.
Applications for 2026 are closed. Get ready for the next round.
Whether your startup is already incorporated or still in the making, join the waitlist to be the first to hear when the programs open in 2027.
From the ecosystem
Short posts relaying startup, IP and funding topics (French Tech, Maddyness, partner news) to anchor the economic dimension of MIB Startup Studio.
Upcoming events
Masterclasses, partnering days and flagship events. A dedicated events feed can be added here as content grows.
Join the waitlist or get in touch.
Tell us your profile: your request goes to the right person, and everyone on the waitlist is the first to hear when applications open.